Skip to content
Clinical Trials – home
Therapeutic area

Reproductive system and breast disorders – page 12

  • 956 clinical trials
  • 391 recruiting
  • 345 conditions
  • 28 countries

Conditions in this area

345 conditions with trials, the busiest first

Clinical trials in Reproductive system and breast disorders

956 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

956 clinical trials

Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Karolinska University Hospital
Countries:SpainSpain
  • Participants:18–64 years · Healthy volunteers
  • Substances:Corifollitropin Alfa
  • Sponsor:Ivi Valencia S.L.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Capecitabine
  • Sponsor:Turku University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Substances:Everolimus
  • Sponsor:Odense University Hospital
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:Metformin Hydrochloride
  • Sponsor:Karolinska Institutet
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
  • Sponsor:Region Stockholm
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Codeine Phosphate
  • Sponsor:Merck Sharp & Dohme LLC
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Choriogonadotropin Alfa
  • Sponsor:Region Hovedstaden
Investigational
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:N-[4-[2-[4-(3-Cyanophenyl)Piperazin-1-Yl]Ethyl]Cyclohexyl]-3-Methoxypropanamide
  • Sponsor:Bioprojet Pharma
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Follitropin Alfa
  • Sponsor:Amsterdam UMC Stichting
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Fluoroestradiol F-18
  • Sponsor:Centre Hospitalier Universitaire De Toulouse
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cabazitaxel
  • Sponsor:Swiss Group for Clinical Cancer Research

Substances studied in this area

The therapies tested most often in Reproductive system and breast disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.